Rapport Therapeutics, Inc. RAPP

33.91 0.08 0.24% as of 25 Sep
Market cap
$1.6B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22
Cash and Short Term Investments
490.64 305.39 147.56 31.16
Total current assets
498.56 309.80 150.87 31.27
Property, Plant, Equpment (Net)
2.98 3.53 1.92 0.34
Long-term assets (Other)
0.99 0.16 0.55 —
Total non-current assets
13.87 5.13 4.55 0.34
Total Assets
512.43 314.93 155.42 31.60
Accounts Payable
4.19 1.95 2.50 1.45
Accrued Expenses
12.10 6.08 5.63 0.21
Total current liabilities
19.05 8.77 8.80 1.66
Liabilities (Preferred Stock)
— — 4.20 10.44
Total non-current liabilities
8.73 0.74 5.68 10.44
Total liabilities
27.78 9.51 14.48 12.10
Additional Paid In Capital
719.29 429.66 19.80 0.59
Preferred Stock (Total)
— — 166.58 29.57
Common Stock (Net)
0.05 0.04 0.00 0.00
Retained Earnings
(235.23) (123.74) (45.44) (10.65)
Common Equity (Total)
484.65 305.43 (25.63) (10.06)
Shareholders Equity (Total)
484.65 305.43 140.94 19.51
Shareholders Equity and Liabilities (Total)
512.43 314.93 155.42 31.60
Shares (Common)
47.77 36.58 4.17 3.59
Shares (Preferred)
— 0.00 151.46 40.18
Shareholders Equity (Tangible)
484.65 305.43 140.94 19.51
Net Debt
(490.64) (305.38) (147.56) (31.16)

Fold the line items

In millions of $ except per-share values · columns are period end dates